Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.20
Bid: 171.00
Ask: 171.60
Change: 2.80 (1.66%)
Spread: 0.60 (0.351%)
Open: 167.00
High: 171.20
Low: 167.00
Prev. Close: 168.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant under Performance Share Plan

30 Apr 2021 13:11

RNS Number : 2690X
Forterra plc
30 April 2021
 

30 April 2021

Forterra plc

Grant under Performance Share Plan

Forterra plc (the "Company") announces that on 30 April 2021 awards over ordinary shares of £0.01 each in the capital of the Company were granted to certain Directors and persons discharging managerial responsibility ("PDMRs") under the Forterra plc Performance Share Plan ("PSP") as follows:

Name of Director / PDMR

Number of Shares over which the PSP Award is granted

Stephen Harrison

(Chief Executive Officer) 

222,112

Ben Guyatt

(Chief Financial Officer)

131,356

George Stewart

(Operations Director)

40,257

Adam Smith

(Commercial Director)

40,257

Shahbaz Idriss

(HR Director)

35,593

Darren Rix

(Managing Director - Bison Flooring)

30,035

Matt Day

(IT Director)

32,767

Peter Varnsverry

(Strategy Director)

43,484

Ashley Thompson

(Company Secretary)

8,706

Other management

 

174,138

Total awards granted

 

758,705

No consideration was paid for the grant of the awards which are structured as nominal cost options at an option exercise price of £0.01 per Ordinary Share. The number of Ordinary Shares granted under the award has been calculated using a share price of £2.95 being an average mid-market quotation as derived from the London Stock Exchange Daily Official List for the last 5 days of trading.

The vesting of an award is subject to the satisfaction of performance conditions which have been set by the Remuneration Committee of the Board of Directors of the Company. Half of the awards are subject to TSR and EPS performance measures respectively. The awards will normally vest on 30 April 2024, subject to the achievement of the performance conditions and the participant being a director or employee within the Company's group at that time.

Further information regarding the PSP is set out in the Annual Report and Accounts.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

 

 

Ashley Thompson (Company Secretary)

 

 

 

 

FTI Consulting (public relations adviser to Forterra):

+44 (0) 20 3727 1340

Richard Mountain

 

Nick Hasell

 

Forterra plc

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDSGBXDGBG
Date   Source Headline
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20224:32 pmRNSEmployee Benefit Trust Share Purchase
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:00 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research
25th Nov 20217:00 amRNSTrading Update
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.